查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1689881

聚乙烯吡咯烷酮：市场占有率分析、产业趋势与统计、成长预测（2025-2030 年）

Polyvinylpyrrolidone - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计预测期内聚乙烯吡咯烷酮市场复合年增长率将超过 8%。

聚乙烯吡咯烷酮-市场-IMG1

在 COVID-19 疫情期间，由于终端用户应用需求减少，聚乙烯吡咯烷酮的需求下降。全球长期停工导致建筑业劳动力短缺和供应链中断，影响了建筑业关键应用——对黏合剂的需求。此外，疫情期间，对人员流动的严格限制导致包装食品和速食食品、化妆品和个人保健产品的零售额放缓。另一方面，由于製药业的持续成长，医药领域对聚乙烯吡咯烷酮的需求略有改善。不过，现在製造业已完全恢復到疫情前的活动水平，预计未来几年对聚乙烯吡咯烷酮的需求将稳定成长。

主要亮点

  • 聚乙烯吡咯烷酮广泛用于製药工业，作为锭剂生产中的粘合剂。随着疫情过后世界主要经济体纷纷加大对製药业的投入，预计该领域的研究市场需求将出现强劲成长。
  • 此外，住宅和商业建筑需求的不断增长导致全球建设活动增加，预计这将进一步推动对聚乙烯吡咯烷酮的需求。
  • 然而，所研究的市场可能会受到在各种应用中取代聚乙烯吡咯烷酮的替代品的影响。
  • 另一方面，个人护理和化妆品行业不断扩大的应用前景或为研究市场提供未来的成长机会。
  • 亚太地区占据市场主导地位，预计在预测期内将继续保持主导地位。

聚乙烯吡咯烷酮市场趋势

製药业需求不断成长

  • 聚乙烯吡咯烷酮（PVP）具有优良的溶解性、增溶性、结合强度、络合强度等，在医药卫生领域中用作粘合剂、被覆剂、助溶剂、消毒剂、增溶剂、缓释剂、胶囊壳、分散稳定剂等。
  • 製药业和药品可能是最早和最知名地受益于 PVP 的行业，因为 PVP 具有优异的生物相容性，并且能够与多种活性物质形成稳定的缔合物和复合物。
  • 中国、印度、美国和德国拥有世界上最大的製药产业。据估计，全球约40%的原料药由中国製造商生产。此外，中国和印度供应了美国进口的75%至80%的原料药。降低成本和放宽环境法规的愿望正在推动中国和印度製药业的发展。
  • 据Astra Zeneca称，预计2024年北美的医药销售额将达到6,330亿美元，其次是欧盟（不包括英国），销售额为2,870亿美元，东南亚和东亚为2,320亿美元。
  • 製药业是美国的主要产业之一，也是美国研发最密集的产业之一。据Astra Zeneca称，美国製药业是全球最大的製药业，2022年占全球医药销售额的49.8%，销售额达6,050亿美元。
  • 美国人口的成长和老化正在刺激製药业的扩张。此外，美国口中有 15% 年龄在 65 岁或以上，预计到 2023 年这一比例还会增加。
  • 根据英国製药工业协会（ABPI）估计，英国製药业年营业额约502.1亿欧元（约583.6亿美元）。市场的主要企业包括GlaxoSmithKline Plc和Astra Zeneca。此外，该国也是向世界各地患者出口救命药品的主要国家之一。
  • 2022年，英国向全球出口了价值254亿欧元（295.2亿美元）的医药和医疗产品，进口了价值约308亿欧元的产品，导致亏损约54亿欧元（62.8亿美元）。
  • 预计预测期内製药业的这些趋势将增加所研究市场的需求。

亚太地区占市场主导地位

  • 预计预测期内聚乙烯吡咯烷酮市场将由亚太地区主导。由于製药业的发展，中国、印度和日本等国家对聚乙烯吡咯烷酮的需求正在增加。
  • 在我国，聚乙烯吡咯烷酮（PVP）被广泛应用于製药工业作为安全的黏合剂和血浆扩容剂。中国製药业是世界上最大的製药业之一。该国生产学名药、治疗药物、原料药和草药。
  • 日本註册的药品90%以上都是学名药。为发展医疗保健产业，政府实施了「健康中国2030」策略，目标是到2030年将市场规模扩大到2.4兆美元。
  • 根据Invest India的报告，预计2024年印度製药业的市场规模将达到650亿美元，到2030年将进一步达到1,300亿美元。这有望增加药品产量并满足该国的市场需求。
  • 以产量计算，印度是世界第三大药品生产国，以金额计算，印度是世界第十四大药品生产国。印度製药业对印度GDP的贡献约2%，对商品出口总额的贡献约8%。
  • 同时，根据印度品牌股权基金会的数据，预计到 2022 年印度外出用餐市场的价值将达到近 410 亿美元。快餐店占了很大的金额。从细分市场来看，与前一年同期比较，但非正规部门仍主导着餐饮业。
  • 食品业的收益正在大幅增长，研究表明，预计到 2025 年将增长到 11,631.9 亿美元。此外，根据印度医学研究理事会 (ICMAR) 的数据，印度冷冻食品市场预计在 2019 年至 2024 年间将成长 17%，这可能会刺激食品应用研究市场的需求。
  • 根据美国农业部（USDA）统计，日本食品业预计2022年食品产量将达1,900亿美元，较2021年下降12.4%。不过，酒精饮料、软性饮料、鱼製品和其他健康食品类别的产量增加。
  • 为了促进化妆品产业的成长，东京化妆品工业协会、日本化妆品工业协会、西日本化妆品工业协会、中部化妆品工业协会于2023年4月合併成立日本化妆品工业协会。
  • 考虑到上述因素，预计预测期内该地区对聚乙烯吡咯烷酮的需求将会成长。

聚乙烯吡咯烷酮产业概况

聚乙烯吡咯烷酮市场本质上是整合的。前五大公司占据了大部分市场份额。市场的主要企业包括BASF欧洲公司、亚什兰、博爱新开源製药有限公司、四川天华化工集团和锦华南航生命科学。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动程式
    • 製药业需求不断成长
    • 扩大作为建设产业黏合剂的用途
  • 限制因素
    • 替代方案的可用性
  • 价值链分析
  • 波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第五章 市场区隔

  • 形式
    • 粉末
    • 液体
  • 应用
    • 药品
    • 饮食
    • 化妆品
    • 胶水
    • 其他用途
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 其他亚太地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 义大利
      • 法国
      • 其他欧洲国家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区
    • 中东和非洲
      • 沙乌地阿拉伯
      • 南非
      • 其他中东和非洲地区

第六章 竞争格局

  • 併购、合资、合作、协议
  • 市场占有率（%）分析
  • 主要企业策略
  • 公司简介
    • Ashland
    • BASF SE
    • Boai NKY Pharmaceuticals Ltd.
    • Glide Chem Private Limited
    • Hangzhou Motto Science & Technology Co. Ltd.
    • JH Nanhang Life Sciences Co. Ltd.
    • Nippon Shokubai Co. Ltd.
    • Shanghai Qifuqing Material Technology Co. Ltd.
    • Shanghai Yuking Water Soluble Material Tech Co. Ltd.
    • Sichuan Tianhua Chemical Group Co. Ltd.
    • Thermo Fisher Scientific Inc.
    • Zhangzhou Huafu Chemical Co. Ltd.

第七章 市场机会与未来趋势

  • 扩大个人护理和化妆品行业的应用范围
  • 其他机会
简介目录
Product Code: 69095

The Polyvinylpyrrolidone Market is expected to register a CAGR of greater than 8% during the forecast period.

Polyvinylpyrrolidone - Market - IMG1

During the outbreak of the COVID-19 pandemic, demand for polyvinylpyrrolidone declined due to reduced demand from end-user applications. Prolonged lockdowns worldwide resulted in labor shortages and supply chain disruptions in the construction segment, affecting the demand for adhesives that find major applications in the segment. Furthermore, with strict restrictions on people's movement, retail sales for packaged and fast food, cosmetics, and personal care products slumped during the pandemic. On the flip side, the continued growth of the pharmaceutical industry slightly improved the demand for polyvinylpyrrolidone in pharmaceutical applications. However, with the manufacturing sector now fully restored to pre-pandemic levels of activity, demand for polyvinylpyrrolidone is anticipated to grow steadily during the next several years.

Key Highlights

  • Polyvinylpyrrolidone is extensively used in the pharmaceutical industry as a binder in the manufacturing of tablets. With major economies across the globe spending on developing the pharmaceutical industry in the aftermath of the pandemic, the demand for the studied market is projected to experience strong growth in the segment.
  • Furthermore, growing construction activities across the globe, in view of rising demand for residential and commercial construction, are anticipated to further boost demand for polyvinylpyrrolidone.
  • However, the studied market could likely be affected by the presence of substitute products that can potentially replace polyvinylpyrrolidone across various applications.
  • On the flip side, an increasing application scope in the personal care and cosmetics industry may present future growth opportunities for the studied market.
  • Asia-Pacific dominated the market and is expected to continue its dominance during the forecast period, major supported by the extensive growth of the pharmaceutical segment in the region.

Polyvinylpyrrolidone Market Trends

Rising Demand in the Pharmaceutical Industry

  • Polyvinylpyrrolidone or PVP can be used in medical and health fields as a binder, excipient, coating, bounded solution of an agent, cosolvent, sterilization disinfectant, solubilizer, sustained release agent, capsule shell, dispersion stabilizer, others due to its excellent solubility, solubilization property, bonding capacity, complexing power, and other functions.
  • The pharmaceutical industry and medicine are the earliest and probably the most well-known areas to have benefited from PVP due to its extraordinary biocompatibility and ability to create stable association compounds and complexes with various active substances.
  • China, India, the United States, and Germany are the largest pharmaceutical industries in the world. It is estimated that Chinese manufacturers make up around 40% of all the APIs used worldwide. Additionally, China and India are the sources of 75% to 80% of the APIs imported to the United States. The desire for cost savings and less stringent environmental regulations has been driving the pharmaceutical industries in China and India.
  • According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America holding the major share, followed by the European Union (excluding the United Kingdom) with USD 287 billion at the second position, then Southeast and East Asia expected to register USD 232 billion.
  • The pharmaceutical sector is one of the major industries in the United States and one of the country's most research and development-intensive industries. According to AstraZeneca, the pharmaceutical industry in the United States is the largest globally, accounting for 49.8% of global pharmaceutical sales in 2022, with sales amounting to USD 605 billion.
  • The United States' expanding and aging population is fuelling the expansion of the pharmaceutical industry. Moreover, 15% of the population in the United States is over 65, and this percentage is predicted to expand by 2023.
  • According to the Association of the British Pharmaceutical Industry (ABPI), the annual turnover of the United Kingdom's pharmaceutical industry is estimated at around EUR 50.21 billion (USD 58.36 billion). Some of the key players in the market include GlaxoSmithKline and AstraZeneca. Furthermore, the country is one of the major exporters of life-saving drugs to patients across the world.
  • In 2022, the United Kingdom exported EUR 25.4 billion (USD 29.52 billion) worth of pharmaceutical and medicinal products around the world and imported around EUR 30.8 billion worth of products, with the trade deficit standing at approximately EUR 5.4 billion (USD 6.28 billion).
  • Such trends in the pharmaceutical industry are anticipated to augment demand for the studied market during the forecast period.

Asia-Pacific Region to Dominate the Market

  • The Asia-Pacific region is expected to dominate the market for polyvinylpyrrolidone during the forecast period. In countries like China, India, and Japan, the demand for polyvinylpyrrolidone has been increasing in the region due to the growing pharmaceutical industry.
  • In China, polyvinylpyrrolidones (PVP) are widely adopted as a safe binder and blood plasma expander in the pharma industry. The pharmaceutical industry in China is one of the largest in the world. The country produces generics, therapeutic medicines, active pharmaceutical ingredients, and traditional Chinese medicine.
  • More than 90% of the drugs registered in the country are generic. The government has implemented the "Healthy China 2030" initiative for developing the healthcare industry, which aims for the market to reach a value of USD 2.4 trillion by 2030.
  • According to a report by Invest India, the pharmaceutical industry in India is anticipated to reach a market value of USD 65 billion by the year 2024, with further growth projected to reach USD 130 billion by 2030. This is anticipated to increase the production of pharmaceutical goods and, thereby, is likely to benefit the market demand in the country.
  • India ranks 3rd worldwide for production by volume and 14th by value. The Indian pharmaceutical sector contributes about 2% to India's GDP and around 8% to the country's total merchandise exports.
  • On the other hand, according to the India Brand Equity Foundation, the food service market in India was estimated to be nearly USD 41 billion in 2022. Quick-service restaurants accounted for a large value of the market. In terms of segments, the unorganized sector dominated the food service industry, even though the organized market has a significant year-on-year growth.
  • The revenue from the food industry has been growing significantly and is projected to grow to USD 1,163.19 billion in 2025, as per the study. Moreover, the Indian frozen food market is expected to grow by 17% from 2019 to 2024, according to the Indian Council of Medical Research (ICMAR), thereby potentially augmenting demand for the studied market in food applications.
  • According to the US Department of Agriculture (USDA), the Japanese food industry produced food valued at USD 190 billion in 2022, declining by 12.4% in comparison to 2021. However, an increase in production was seen in alcoholic beverages, soft drinks, fish products, and other health food categories.
  • To facilitate the growth of the cosmetic industry, the Japan Cosmetic Industry Association (JCIA) was established in April 2023 by integrating the Tokyo Cosmetic Industry Association, the Japan Cosmetic Industry Federation, the West Japan Cosmetic Industry Association, and the Chubu Cosmetic Industry Association.
  • Thus, the factors above indicate a growing demand for polyvinylpyrrolidone in the region during the forecast period.

Polyvinylpyrrolidone Industry Overview

The polyvinylpyrrolidone market is consolidated in nature. The top five players account for a major share of the market. Major companies in the market include BASF SE, Ashland, Boai NKY Pharmaceuticals Ltd., Sichuan Tianhua Chemical Group Co., Ltd., and JH Nanhang Life Sciences Co., Ltd, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Rising Demand in the Pharmaceutical Industry
    • 4.1.2 Growing Application as Adhesives in the Construction Industry
  • 4.2 Restraints
    • 4.2.1 Presence of Substitutes
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Form
    • 5.1.1 Powder
    • 5.1.2 Liquid
  • 5.2 Application
    • 5.2.1 Pharmaceutical
    • 5.2.2 Food and Beverage
    • 5.2.3 Cosmetics
    • 5.2.4 Adhesives
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%) Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Ashland
    • 6.4.2 BASF SE
    • 6.4.3 Boai NKY Pharmaceuticals Ltd.
    • 6.4.4 Glide Chem Private Limited
    • 6.4.5 Hangzhou Motto Science & Technology Co. Ltd.
    • 6.4.6 JH Nanhang Life Sciences Co. Ltd.
    • 6.4.7 Nippon Shokubai Co. Ltd.
    • 6.4.8 Shanghai Qifuqing Material Technology Co. Ltd.
    • 6.4.9 Shanghai Yuking Water Soluble Material Tech Co. Ltd.
    • 6.4.10 Sichuan Tianhua Chemical Group Co. Ltd.
    • 6.4.11 Thermo Fisher Scientific Inc.
    • 6.4.12 Zhangzhou Huafu Chemical Co. Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Increasing Application Scope in the Personal Care and Cosmetic Industry
  • 7.2 Other Opportunities